Net Cash Provided by (Used in) Operating Activities |
-967K |
USD |
-348% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
981K |
USD |
-79.3% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
213K |
USD |
+476% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
30M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
14M |
shares |
+0.53% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
227K |
USD |
-95.6% |
Q1 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
236K |
USD |
+15.7% |
Q1 2024 |
Q1 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2024 |
Q2 2024 |
Deferred Tax Assets, Gross |
1.86M |
USD |
-30.3% |
Q4 2022 |
FY 2022 |
Deferred Income Tax Expense (Benefit) |
41K |
USD |
-69.6% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
92K |
USD |
-25.2% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Additional Paid in Capital |
35.2M |
USD |
+4.64% |
Q2 2024 |
Q2 2024 |
Depreciation, Depletion and Amortization |
698K |
USD |
+0.14% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
2.08M |
USD |
+12.2% |
Q4 2023 |
FY 2023 |
Interest Expense |
1.03M |
USD |
-3.47% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |